2 excellent ASX growth shares that analysts say are buys

Analysts say these ASX growth shares are buys…

| More on:
a man raises his fists to the air in joyous celebration while learning some exciting good news via his computer screen in an office setting.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you interested in adding some ASX growth shares to your portfolio in November? If you are, you may want to look at the two listed below that have recently been named as buys.

Here's what you need to know about them:

Allkem Ltd (ASX: AKE)

The first ASX growth share that could be a buy this month is Allkem.

Allkem is the lithium giant that owns a collection of quality projects across several product types. These operations include Olaroz, Mt Cattlin, and the Sal de Vida brine project.

Lithium certainly is a great commodity to be working with right now. With lithium prices at sky high levels and tipped to stay that way in the near term, Allkem appears well-positioned to deliver bumper earnings in the coming years. Particularly given management's plan to grow its production 3x by 2026 and command a 10% share of global lithium production over the long term.

Macquarie is very positive on the company's outlook and has an outperform rating and $21.00 price target on its shares.

Temple & Webster Group Ltd (ASX: TPW)

Another ASX growth share that has been named as a buy is Temple & Webster.

It is Australia's leading pure-play online retailer of furniture and homewares.

Temple & Webster has been growing at a strong rate for a number of years thanks to the shift to online shopping. And with the shift in this category still in its early stages compared to other categories, the company appears well-placed to continue benefiting and growing strongly for some time to come.

Goldman Sachs expects that to be the case. In addition, the broker highlights that the category favours scale players, requires a specialised approach to e-commerce, and has higher barriers to entry. This all bodes well for Temple & Webster.

Goldman has a buy rating and $7.55 price target on the company's shares.

Motley Fool contributor James Mickleboro has positions in Allkem Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group Ltd. The Motley Fool Australia has recommended Temple & Webster Group Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 ASX growth shares to snap up while they're still down

Brokers see plenty of upside for these mainstay sector picks.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

Why these ASX growth stocks could be much bigger in 2030 than today

These stocks have long growth runways and strong business models.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Growth Shares

3 incredible ASX growth shares to buy and hold forever in 2026

True long-term investing means owning businesses you’d be happy to hold through volatility, uncertainty, and decades of change.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 shares to buy hand over fist before the ASX 200 soars higher in 2026

These shares are highly rated by brokers for a reason. Here's what you need to know about them.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 unstoppable ASX 200 stocks to buy in 2026 and hold forever

These blue chips could have very bright futures. Do you own them?

Read more »

A man sees some good news on his phone and gives a little cheer.
Growth Shares

5 incredible ASX growth stocks to buy for 2026

These growth stocks could be well-positioned for the long-term.

Read more »